News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
435,016 Results
Type
Article (19500)
Company Profile (84)
Press Release (415425)
Multimedia
Podcasts (27)
Webinars (8)
Section
Business (133882)
Career Advice (1150)
Deals (24204)
Drug Delivery (67)
Drug Development (46338)
Employer Resources (83)
FDA (9927)
Job Trends (8924)
News (216583)
Policy (18198)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (1290)
Accelerated approval (17)
Adcomms (8)
Allergies (63)
Alliances (30370)
ALS (113)
Alzheimer's disease (946)
Antibody-drug conjugate (ADC) (217)
Approvals (10178)
Artificial intelligence (385)
Autoimmune disease (113)
Automation (26)
Bankruptcy (194)
Best Places to Work (7271)
BIOSECURE Act (7)
Biosimilars (113)
Biotechnology (71)
Bladder cancer (108)
Brain cancer (30)
Breast cancer (363)
Cancer (3097)
Cardiovascular disease (234)
Career advice (975)
Career pathing (15)
CAR-T (209)
CDC (16)
Cell therapy (509)
Cervical cancer (22)
Clinical research (40397)
Collaboration (1214)
Compensation (518)
Complete response letters (22)
COVID-19 (1532)
CRISPR (53)
C-suite (596)
Cystic fibrosis (101)
Data (4230)
Denatured (7)
Depression (96)
Diabetes (301)
Diagnostics (4419)
Digital health (24)
Diversity (5)
Diversity, equity & inclusion (26)
Drug discovery (177)
Drug pricing (83)
Drug shortages (12)
Duchenne muscular dystrophy (131)
Earnings (64191)
Editorial (32)
Employer branding (12)
Employer resources (76)
Events (66089)
Executive appointments (689)
FDA (12002)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (5)
Frontotemporal dementia (14)
Funding (985)
Gene editing (115)
Generative AI (44)
Gene therapy (341)
GLP-1 (547)
Government (2051)
Grass and pollen (3)
Guidances (359)
Healthcare (11447)
HIV (37)
Huntington's disease (31)
IgA nephropathy (56)
Immunology and inflammation (139)
Immuno-oncology (38)
Indications (65)
Infectious disease (1687)
Inflammatory bowel disease (122)
Inflation Reduction Act (8)
Influenza (69)
Intellectual property (154)
Interviews (176)
IPO (11798)
IRA (17)
Job creations (1969)
Job search strategy (826)
JPM (36)
Kidney cancer (13)
Labor market (34)
Layoffs (296)
Leadership (19)
Legal (4895)
Liver cancer (59)
Longevity (8)
Lung cancer (408)
Lymphoma (260)
Machine learning (33)
Management (26)
Manufacturing (517)
MASH (104)
Medical device (8212)
Medtech (8242)
Mergers & acquisitions (13183)
Metabolic disorders (748)
Multiple sclerosis (96)
NASH (12)
Neurodegenerative disease (188)
Neuropsychiatric disorders (54)
Neuroscience (1752)
Neurotech (1)
NextGen: Class of 2026 (3528)
Non-profit (2266)
Now hiring (12)
Obesity (341)
Opinion (173)
Ovarian cancer (115)
Pain (95)
Pancreatic cancer (132)
Parkinson's disease (184)
Partnered (22)
Patents (300)
Patient recruitment (318)
Peanut (23)
People (38708)
Pharmaceutical (17)
Pharmacy benefit managers (17)
Phase 1 (12786)
Phase 2 (17540)
Phase 3 (13687)
Pipeline (4007)
Policy (110)
Postmarket research (1363)
Preclinical (5091)
Press Release (69)
Prostate cancer (149)
Psychedelics (23)
Radiopharmaceuticals (228)
Rare diseases (501)
Real estate (3197)
Recruiting (28)
Regulatory (13835)
Reports (27)
Research institute (1261)
Resumes & cover letters (199)
Rett syndrome (21)
RNA editing (6)
RSV (41)
Schizophrenia (112)
Series A (171)
Series B (128)
Service/supplier (3)
Sickle cell disease (59)
Special edition (7)
Spinal muscular atrophy (81)
Sponsored (31)
Startups (2114)
Stomach cancer (4)
Supply chain (58)
Tariffs (33)
The Weekly (20)
Vaccines (592)
Venture capital (46)
Weight loss (210)
Women's health (38)
Worklife (6)
Date
Today (33)
Last 7 days (394)
Last 30 days (1357)
Last 365 days (20452)
2026 (1959)
2025 (20646)
2024 (23554)
2023 (26912)
2022 (35786)
2021 (38115)
2020 (35119)
2019 (27423)
2018 (21112)
2017 (20366)
2016 (18928)
2015 (22962)
2014 (17237)
2013 (13819)
2012 (14723)
2011 (15430)
2010 (14430)
Location
Africa (461)
Alabama (37)
Alaska (4)
Arizona (131)
Arkansas (4)
Asia (25785)
Australia (4037)
California (7635)
Canada (2474)
China (723)
Colorado (303)
Connecticut (317)
Delaware (204)
Europe (57164)
Florida (1133)
Georgia (216)
Hawaii (3)
Idaho (42)
Illinois (515)
India (54)
Indiana (262)
Iowa (14)
Japan (333)
Kansas (94)
Kentucky (32)
Louisiana (18)
Maine (69)
Maryland (947)
Massachusetts (5546)
Michigan (273)
Minnesota (338)
Mississippi (5)
Missouri (85)
Montana (25)
Nebraska (14)
Nevada (88)
New Hampshire (47)
New Jersey (2268)
New Mexico (18)
New York (1942)
North Carolina (860)
North Dakota (8)
Northern California (3895)
Ohio (196)
Oklahoma (6)
Oregon (17)
Pennsylvania (1368)
Puerto Rico (15)
Rhode Island (30)
South America (641)
South Carolina (24)
Southern California (2835)
Tennessee (113)
Texas (1051)
United States (26461)
Utah (207)
Vermont (1)
Virginia (182)
Washington D.C. (43)
Washington State (614)
West Virginia (4)
Wisconsin (89)
Wyoming (2)
435,016 Results for "intermagnetics general corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Approvals
Amgen Scores Uplizna Expansion Into Generalized Myasthenia Gravis
Generalized myasthenia gravis is Uplizna’s second new indication this year, after the FDA cleared the anti-CD19 antibody for IgG4-related disease in April.
December 12, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Salarius Pharmaceuticals Changes Corporate Name to Decoy Therapeutics and Nasdaq Ticker Symbol to DCOY Reflecting Focus on Next-Generation Peptide Conjugate Therapeutics
January 8, 2026
·
5 min read
Press Releases
Genelux Corporation Reports Third Quarter 2025 Financial Results and Provides General Business Updates
November 6, 2025
·
9 min read
Press Releases
Orion Corporation’s financial reporting and Annual General Meeting in 2026
July 18, 2025
·
1 min read
Press Releases
Salarius Pharmaceuticals Announces Planned Corporate Name and Ticker Symbol Change to Decoy Therapeutics, Reflecting Strategic Pivot to Next-Generation Antiviral and Peptide-Conjugate Platform
December 19, 2025
·
6 min read
Manufacturing
FDA Continues US Manufacturing Drive With Domestic Generics Pilot
This latest FDA program aims to provide speedier reviews for generic drugmakers who produce their products in the U.S.
October 6, 2025
·
2 min read
·
Tristan Manalac
Artificial Intelligence
Generate’s Chief IP ‘Geek’ Wants To Answer AI’s Biggest Legal Questions
Generate:Biomedicines’ Nicole Clouse is one of the key legal minds trying to understand who owns what AI creates. The answers are critical to the future of biotech.
August 27, 2025
·
5 min read
·
Annalee Armstrong
Press Releases
AINGENS MACg Slide Generator
January 2, 2026
·
1 min read
Opinion
How To Bring Generic Drug Manufacturing Back to the US
Reshoring generic pharmaceutical production is essential in today’s era of geopolitical instability and heightened awareness surrounding national health security. And it is possible—if done right.
September 30, 2025
·
5 min read
·
Vic Suarez
Layoffs
Generation Bio Boots 90% of Staff Amid Dwindling Cash Reserves
The layoffs will not spare Generation’s R&D team, which will initially be retained while the biotech completes its strategic review but will eventually be let go.
August 13, 2025
·
2 min read
·
Tristan Manalac
1 of 43,502
Next
